Navigation Links
NicOx to Present at Financial Conferences in New York on November 27, 28 and 29
Date:11/21/2007

SOPHIA ANTIPOLIS, France, November 21 /PRNewswire-FirstCall/ -- Michele Garufi, Chairman and CEO of NicOx (Eurolist: COX), will provide an update on the progress of the Company's research and development programs and the status of ongoing alliances at three financial conferences in New York during the week of November 26, 2007:

- At the 19th Annual Piper Jaffray Health Care Conference on November 28 at 15:00 US Eastern Time (21:00 Central European Time - 20:00 UK Time) at the Pierre New York Hotel. To access the live audio broadcast of the presentation or its subsequent archived recording please logon to http://www.nicox.com. Please connect to the website several minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary.

- At the Lazard Capital Markets 4th Annual Health Care conference on November 27th at 14:00 US Eastern Time (20:00 Central European Time - 19:00 UK Time) at the New York Palace Hotel (no live audio broadcast or archived recording of the presentation will be available).

- In addition, NicOx will participate in the Natixis Securities Mid-Cap Euro Healthcare Seminar on November 29 at the Warwick Hotel.

NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) (OTC: NICXF) is a product-driven biopharmaceutical company dedicated to the development of nitric oxide-donating drugs to meet unmet medical needs. NicOx is targeting the therapeutic areas of pain and inflammation and cardio-metabolic disease. Resources are focused on two lead compounds, naproxcinod (formerly HCT 3012); in phase 3 development for the treatment of signs and symptoms of osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes.

NicOx has strategic partnerships with some of the world's leading pharmaceutical companies, including Pfizer Inc. and Merck and Co., Inc.

NicOx S.A. is headquartered in Sophia-Antipolis, France, and is a public company listed on the Eurolist of EuronextTM Paris (segment: Next Economy).

The elements included in this communication may contain forward-looking statements subject to certain risks and uncertainties. Actual results of the company may differ materially from those indicated in the forward-looking statements because of different risks factors described in the company's document de reference.

CONTACTS: http://www.nicox.com

NicOx:

Karl Hanks - Manager of Corporate Relations and Market Analysis -

Tel +33-(0)4-97-24-53-42 - hanks@nicox.com

Investors in the United States

Burns McClellan:

Lisa Burns - Tel +1-212-213-0006 - lburns@burnsmc.com

Juliane Snowden - jsnowden@burnsmc.com

Media in the United States

FD - Jonathan Birt -

Tel +1-212-850-56-34 - jbirt@fd-us.com

Media in Europe -

Citigate Dewe Rogerson:

Valerie Auffray -

Tel: +44-(0)207-282-2979 - valerie.auffray@citigatedr.co.uk

David Dible -

Tel +44-(0)207-282-2949 - david.dible@citigatedr.co.uk


'/>"/>
SOURCE NicOx
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. NicOx Opens U.S. Headquarters in New Jersey
2. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
3. Avicena Group to Present at Noble Financial Conference
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. CEL-SCI to Present at the Noble Financial Conference
8. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Strategic Diagnostics Updates Roth Conference Presentation Time
11. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Feb. 12, 2016  PTC Therapeutics, Inc. ... annual STRIVE (Strategies to Realize Innovation, Vision and ... (DMD). STRIVE provides funds to patient advocacy organizations ... make meaningful contributions to the rare disease community ... of future patient advocates. Mary ...
(Date:2/11/2016)... NBIX ) today announced its financial results for the quarter ... --> For the fourth quarter of 2015, the ... per share, compared to a net loss of $19.4 million, or ... the year ended December 31, 2015, the Company reported a net ... to a net loss of $60.5 million, or $0.81 loss per ...
(Date:2/11/2016)... , Feb. 11, 2016  Bioethics International, a not-for-profit organization ... researched, developed, marketed and made accessible to patients around the ... had named the publication of the Good Pharma ... publication is also featured as one of BMJ Open ... last year that are most frequently read. Ed ...
(Date:2/11/2016)... (PRWEB) , ... February 11, ... ... business-to-business publication dedicated to delivering cutting-edge information focused on the development and ... Sciences to become a premier sponsor of the 2016 BioProcess International Awards ...
Breaking Biology Technology:
(Date:1/18/2016)... JOSE, Calif. , Jan. 18, 2016 /PRNewswire/ ... security software that simplifies the use and access ... technology and go-to-market partnership with American Cyber.  ... Cyber brings extensive experience leading transformational C4ISR and ... implementing and integrating the latest proven technology solutions," ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/11/2016)... , Jan. 11, 2016 Synaptics Incorporated ... interface solutions, today announced that its ClearPad ® ... (TDDI) products won two separate categories in the 8 ... Innovator and Best Technology Breakthrough. The Synaptics ® ... a simplified supply chain, thinner devices, brighter displays and ...
Breaking Biology News(10 mins):